4D Molecular Therapeutics Inc (FDMT)

Working Capital Ratio

68.06%

Quarterly · Period ending:

FDMT logo

FDMT Working Capital Ratio

Latest reported65.14%
FDMT FY Working Capital Ratio (68.05% → 65.14%)
High-resolution chart · PNG

FDMT working capital ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

4D Molecular Therapeutics Inc Working Capital Ratio — Annual fiscal periods
Period endingWorking Capital Ratio
65.1388%
72.4116%
81.6841%
78.2063%
67.8786%
92.2246%
67.9208%
88.7026%
68.049%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.